文献速递临床试验与 GCP流行病学与生物统计

痴呆患者及照护者的卫生系统、社区或常规痴呆照护:D-CARE随机临床试验

Health System, Community-Based, or Usual Dementia Care for Persons With Dementia and Caregivers: The D-CARE Randomized Clinical Trial.
PubMed 文献 · JAMA · 2025-01-01

该随机临床试验在美国4个中心纳入社区居住的痴呆患者及照护者,按7:7:1随机分配至卫生系统主导的痴呆照护、社区主导的痴呆照护或常规照护。主要结局(患者神经精神症状严重程度和照护者负担)在三组间均无显著差异;仅照护者自我效能在两种干预组均显著高于常规照护组,但两种干预组间无显著差异。

要点

  • 卫生系统与社区痴呆照护在改善患者行为症状和照护者负担上均与常规照护无显著差异。
  • 两种干预组照护者自我效能均显著高于常规照护组,但干预组间无显著差异。
  • 主要结局评估覆盖率超过99%,62%的入组者完成18个月随访。

核心结论

  • 在该随机试验中,卫生系统主导与社区主导的痴呆照护干预之间,以及任一干预与常规照护之间,在患者行为症状和照护者负担方面均无显著差异。

研究设计与样本

  • 随机临床试验,在美国4个中心开展,纳入社区居住的痴呆患者及照护者,入组时间为2019年6月至2023年1月,最终随访为2023年8月。
  • 参与者按7:7:1随机分配至卫生系统主导照护(n=1016)、社区主导照护(n=1016)或常规照护(n=144),共2176对痴呆患者-照护者。

主要发现

  • 主要结局神经精神问卷(NPI-Q)严重程度评分的最小二乘均值:卫生系统组9.8,社区组9.5,常规照护组10.1,组间差异均无统计学显著。
  • 主要结局改良照护者负担指数的最小二乘均值:卫生系统组10.7,社区组10.5,常规照护组10.6,组间差异均无统计学显著。
  • 次要结局照护者自我效能的最小二乘均值:卫生系统组15.1,社区组15.2,常规照护组14.4;卫生系统组 vs 常规照护组差异0.70(95%CI 0.26-1.14),社区组 vs 常规照护组差异0.85(95%CI 0.42-1.29),干预组间差异-0.16(95%CI -0.37至0.06)。

关键数值与推荐

  • NPI-Q评分范围0-36分,分数越高行为症状越严重,最小临床重要差异(MCID)为2.8-3.2。
  • 改良照护者负担指数范围0-26分,分数越高负担越重,MCID为1.5-2.3。
  • 照护者自我效能评分范围4-20分,分数越高自我效能越强。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: The effectiveness of different approaches to dementia care is unknown. OBJECTIVE: To determine the effectiveness of health system-based, community-based dementia care, and usual care for persons with dementia and for caregiver outcomes. DESIGN, SETTING, AND PARTICIPANTS: Randomized clinical trial of community-dwelling persons living with dementia and their caregivers conducted at 4 sites in the US (enrollment June 2019-January 2023; final follow-up, August 2023). INTERVENTIONS: Participants were randomized 7:7:1 to health system-based care provided by an advanced practice dementia care specialist (n = 1016); community-based care provided by a social worker, nurse, or licensed therapist care consultant (n = 1016); or usual care (n = 144). MAIN OUTCOMES AND MEASURES: Primary outcomes were caregiver-reported Neuropsychiatric Inventory Questionnaire (NPI-Q) severity score for persons living with dementia (range, 0-36; higher scores, greater behavioral symptoms severity; minimal clinically important difference [MCID], 2.8-3.2) and Modified Caregiver Strain Index for caregivers (range, 0-26; higher scores, greater strain; MCID, 1.5-2.3). Three secondary outcomes included caregiver self-efficacy (range, 4-20; higher scores, more self-efficacy). RESULTS: Among 2176 dyads (individuals with dementia, mean age, 80.6 years; 58.4%, female; and 20.6%, Black or Hispanic; caregivers, mean age, 65.2 years; 75.8%, female; and 20.8% Black or Hispanic), primary outcomes were assessed for more than 99% of participants, and 1343 participants (62% of those enrolled and 91% still alive and had not withdrawn) completed the study through 18 months. No significant differences existed between the 2 treatments or between treatments vs usual care for the primary outcomes. Overall, the least squares means (LSMs) for NPI-Q scores were 9.8 for health system, 9.5 for community-based, and 10.1 for usual care. The difference between health system vs community-based care was 0.30 (97.5% CI, -0.18 to 0.78); health system vs usual care, -0.33 (97.5% CI, -1.32 to 0.67); and community-based vs usual care, -0.62 (97.5% CI, -1.61 to 0.37). The LSMs for the Modified Caregiver Strain Index were 10.7 for health system, 10.5 for community-based, and 10.6 for usual care. The difference between health system vs community-based care was 0.25 (97.5% CI, -0.16 to 0.66); health system vs usual care, 0.14 (97.5% CI, -0.70 to 0.99); and community-based vs usual care, -0.10 (97.5% CI, -0.94 to 0.74). Only the secondary outcome of caregiver self-efficacy was significantly higher for both treatments vs usual care but not between treatments: LSMs were 15.1 for health system, 15.2 for community-based, and 14.4 for usual care. The difference between health system vs community-based care was -0.16 (95% CI, -0.37 to 0.06); health system vs usual care, 0.70 (95% CI, 0.26-1.14); and community-based vs usual care, 0.85 (95% CI, 0.42 to 1.29). CONCLUSIONS AND RELEVANCE: In this randomized trial of dementia care programs, no significant differences existed between health system-based and community-based care interventions nor between either active intervention or usual care regarding patient behavioral symptoms and caregiver strain. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT03786471.

来源:JAMA,查看原文。版权归原作者所有。

引用

  1. Reuben DB, Gill TM, Stevens A, et al. Health System, Community-Based, or Usual Dementia Care for Persons With Dementia and Caregivers: The D-CARE Randomized Clinical Trial. JAMA. 2025. PMID: 39878968. doi:10.1001/jama.2024.25056

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。